GAM
BSX icon

Generali Asset Management’s Boston Scientific BSX Stock Holding History

Generali Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Buy
80,532
+19,083
+31% +$1.04M 0.06% 235
2026
Q1 		$3.86M Sell
61,449
-33,203
-35% -$2.66M 0.08% 214
2025
Q4 		$9.03M Buy
94,652
+4,914
+5% +$482K 0.18% 110
2025
Q3 		$8.76M Buy
89,738
+6,433
+8% +$666K 0.19% 111
2025
Q2 		$8.95M Sell
83,305
-11,273
-12% -$1.14M 0.2% 106
2025
Q1 		$9.54M Sell
94,578
-25,766
-21% -$2.59M 0.24% 96
2024
Q4 		$10.7M Buy
+120,344
New +$10.6M 0.27% 75

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Generali Asset Management's BSX Position: Q2 2026 in Review

Generali Asset Management increased its Boston Scientific (BSX) stake by 31% in Q2 2026, buying an estimated $1.04M and bringing the position to 80,532 shares worth $3.44M. The position accounts for 0.06% of the portfolio, ranked #235.

Generali Asset Management first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.7M in Q4 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Generali Asset Management held 80,532 shares of Boston Scientific worth $3.44M as of Q2 2026.
  • Generali Asset Management bought 19,083 Boston Scientific shares in Q2 2026, an estimated $1.04M.
  • Boston Scientific made up 0.06% of Generali Asset Management's portfolio in Q2 2026, its #235 holding.
  • Generali Asset Management first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Boston Scientific position peaked at $10.7M in Q4 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.